Order intake declined 3.9% year-over-year due to Middle East instability, but profitability improved with a 15.5% EBITDA margin. Flow and Services divisions grew, while Chemtech faced headwinds and accelerated restructuring. Guidance for 2026 is confirmed, with large orders expected in Q4.Based on…
Order intake declined 3.9% year-over-year due to Middle East instability, but profitability improved with a 15.5% EBITDA margin. Flow and Services divisions grew, while Chemtech faced headwinds and accelerated restructuring. Guidance for 2026 is confirmed.Based on Sulzer AG [SUN] H1 2026 Audio Tran…
Flow and Services divisions achieved growth and margin improvement, while Chemtech stabilized its core business amid project delays. Sales rose 1.0% and EBITDA margin improved to 15.5%, but free cash flow was impacted by higher net working capital. Full-year guidance is confirmed.Original document…
Solid H1 2026 results with improved profitability and resilience amid geopolitical headwinds. Sales and net income grew, while order intake declined slightly; strong margin expansion in Flow and Services offset Chemtech's weakness. Full-year guidance for growth and margin is confirmed.Original docu…
